Our Company
Meet the team working to create a bold new class of cell therapies
Meet the team working to create a bold new class of cell therapies
Hanlan Liu, Ph.D., MBA
SVP, Early Pipeline and Non Clinical Development
Sarah Leach
Sr. Scientist, Cell Therapies
Joanne Smith-Farrell, Ph.D.
Chief Executive Officer & Director
Krishnan Viswanadhan, Pharm.D.
President & Chief Operating Officer
Lea Hachigian, Ph.D.
Co-founder & Vice President, Strategy & Operations
Hanlan Liu, Ph.D., MBA
SVP, Rare Disease & Early Pipeline Research
Joanne Smith-Farrell, Ph.D.
Chief Executive Officer & Director
Arch Venture Partners
Atlas Venture
RA Capital
Alta Partners
Longwood Fund
Bristol Myers Squibb
